Delivery Order SPE2DB20D2014-SPE2DB26FA15M
- Not listed
- This delivery order, valued at $1,570.70, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under an Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,570.70 for Pfizer COVID-19 vaccines (2024-25 formulation, 0.9ml) with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order through its...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9ML) with a firm fixed price structure. The contract, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,304.88 by the Defense Logistics Agency's Medical Supply Chain on October 2, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $9,500.62. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (0.9 mL) under contract 4567983925. This firm fixed-price delivery order, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $1,503.56 on August 27, 2025. The order encompasses Zymfentra 120 mg/ml pens in a 2-pack quantity, with an ultimate completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract...
- This delivery order, awarded September 15, 2025, to AmerisourceBergen Drug Corp represents a $45,231.48 firm fixed-price contract under the Defense Logistics Agency's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. The contract, which is not set-aside and was competitively awarded, will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25, 6-month to 4-year formulation, 0.9 mL) valued at $1,570.70. The contract is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was competitively awarded without any set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award is a delivery order (SPE2DB25FE7XC) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.77 contract is for the delivery of PFIZER COVID 2024-25 (6M-4Y) EUA 0.9ML vaccine doses, with an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA15MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Pfizerpen 5 million unit vials with a ceiling value of $1,551.96 under a firm fixed price contract type. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a competitively awarded, non-set-aside transaction with performance at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs through its comprehensive prime IDV vehicle that enables supply of pharmaceutical products and medical supplies to military healthcare programs and other federal agencies worldwide. The Pfizerpen delivery under this contract supports the DLA's pharmaceutical supply chain operations, which typically serve the Defense Health Agency, U.S. Coast Guard, and related government healthcare systems. This delivery order exemplifies the vendor's role in fulfilling federal medical supply requirements across multiple therapeutic domains and product categories through the flexible IDC structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/22/25 |